TY  - JOUR
AU  - Podzamczer, D
AU  - Rozas, N
AU  - Domingo, P
AU  - Miralles, C
AU  - den Eynde, E Van
AU  - Romero, A
AU  - Deig, E
AU  - Knobel, H
AU  - Pasquau, J
AU  - Antela, A
AU  - Clotet, B
AU  - Geijo, P
AU  - de Castro, E Rodríguez
AU  - Casado, M A
AU  - Muñoz, A
AU  - Casado, A
AU  - For The Pro-Str Study Group,
PY  - 2018
DO  - 10.2174/1570162X17666190212163518
UR  - http://hdl.handle.net/10668/13560
T2  - Current HIV research
AB  - To investigate the impact of switching from stable Combined Antiretroviral Therapy (cART) to single-tablet regimen (RPV/FTC/TDF=EVIPLERA® /COMPLERA®) on patient- reported outcomes in HIV-infected adults who cannot tolerate previous cART, in a...
LA  - en
KW  - Eviplera®
KW  - HIV
KW  - health-related quality-of-life
KW  - patient-reported outcomes
KW  - real-world evidence
KW  - single treatment regimen.
KW  - Adult
KW  - Anti-HIV Agents
KW  - Antiretroviral Therapy, Highly Active
KW  - CD4 Lymphocyte Count
KW  - Drug Combinations
KW  - Drug Substitution
KW  - Female
KW  - HIV Infections
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Patient Reported Outcome Measures
KW  - Prospective Studies
KW  - Quality of Life
KW  - Treatment Outcome
KW  - Viral Load
TI  - Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.
TY  - research article
VL  - 16
ER  -